Close Forward an order
By clicking this button, you can send a message to your purchasing manager to ask her/him to order this product. All information needed about our company and the product will be automatically attached. You will also have the opportunity to ask us for more information about the product. If so, your request will be forwarded to our technical service.

Captcha

* Required Fields

Back to products list

CD43 antibody

Leukosialin
Galactoglycoprotein (GALGP)
Leukocyte sialoglycoprotein
Sialophorin
Gene name : SPN, CD43
One of the major glycoproteins of thymocytes and T lymphocytes. Plays a role in the physicochemical properties of the T-cell surface and in lectin binding. Presents carbohydrate ligands to selectins.

If you want to order offline

orders@covalab.com - tel: +33 (0) 437 654 230 - fax: +33 (0) 437 289 416

Price From: €165.00
Available
Ref : 00014728

* Required Fields

Product Code pab0880-P
Immunogen Synthetic peptide derived from C terminal part of human CD43 protein
Target Specificity Reacts with human CD43 protein.
Name CD43
Uniprot ID P16150
Gene ID 6693
Print datasheet
Product type Primary antibodies
Clonality Polyclonal antibody
Produced in Rabbit
Species Human
Labelling None
Appearance Lyophilized powder
Conc. / Activity 1 mg/ml
Form Purified (protein A)
Constituents Tris 0,1M, glycine 0,1M, sucrose 2%
Preservatives None
Recommendations Must be reconstituted in distilled water.
Storage Lyophilized powder stable for a minimum of 2 years at -20°C.
Store reconstituted antibodies at +4°C.
For extended periods store in aliquots at -20°C.
Antibodies are guaranteed for 6 month from date of receipt.
Applications Western Blot, Immunohistochemistry, ELISA
Working dilutions Optimal dilutions should be determined by the end user.
The following are guidelines only :
WB 1:200 - 1:2000
IHC 1:100 - 1:1500
Research areas Immunology,Signal transduction
Print datasheet
- Fu Q et al. Intracellular patterns of sialophorin expression define a new molecular classification of breast cancer and represent new targets for therapy. Br J Cancer. 2013 Nov 26.
- Fu Q et al. CD43 in the nucleus and cytoplasm of lung cancer is a potential therapeutic target. Int J Cancer. 2013 Apr 15:132(8):1761-70.

WB : CD43 antibody<br/>(pab0880-P)<br/>Anti-CD43 antibody WB staining of 40 µf of total lysate of Jurkat (lane 1) and U937 (lane 2) cells. Antibody pab0880-P dilution 1:1000.<br/>Image from V. Dwivedi, S. Gopalan Sampathkumar, NII, New Dehli

Newsletter Receive news, promotions and offers in your e-mail box